Sorry, you need to enable JavaScript to visit this website.

Studies to Address New Formulations

Lyophilized Formulation Trial

Pfizer and BioNTech initiated a Phase 3 study evaluating a lyophilized (freeze-dried) formulation of the Pfizer-BioNTech COVID-19 vaccine designed to be refrigerator stable.